Fill The House For LLS – On July 1, the Cleveland Indians baseball team is sponsoring a fundraiser event that will benefit the Leukemia & Lymphoma Society (LLS). This event will take place at Progressive Field at 7 p.m, and the tickets will cost $16 if purchased from the LLS, otherwise $22. The Indians will donate $5 for each ticket sold by the LLS and $1 for every other ticket purchased. For more information or to purchase tickets, please visit the LLS Web site.

Institutional Insights – On July 23, this educational program sponsored by the Multiple Myeloma Research Foundation (MMRF) will take place at The Westin Copley Place in Boston. The program will take place from 10:30 a.m. to 2 p.m. Topics to be discussed at the program include advances in diagnosis, frontline therapy, stem cell transplant, managing relapse and bone disease, as well as supportive care. For more information, please visit the MMRF Web site.

BiovaxID Vaccine Released in Europe - BiovaxID is a vaccine with the potential to treat B-cell blood cancers, such as  multiple myeloma. BioVest International released this vaccine, currently used for follicular non-Hodgkin's lymphoma, on a named-patient basis in Europe. A named-patient program allows qualifying patients to receive investigational drugs before being approved by the European Medicines Evaluation Agency. For more information, please see the BioVest press release.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.